hypertriglyceridemia

Ionis Pharma's TRYNGOLZA Receives FDA Approval For Genetic Disorder Treatment
NASDAQ
Thu, 12/19/24 - 09:26 pm
Ionis Pharmaceuticals
FDA
Tryngolza
hypertriglyceridemia
89bio to initiate Phase III trials for pegozafermin in severe hypertriglyceridaemia
Clinical Trials Arena
Wed, 01/11/23 - 10:47 am
89Bio
pegozafermin
clinical trials
hypertriglyceridemia
89bio’s home run fails to excite
EP Vantage
Wed, 06/29/22 - 10:35 am
89Bio
NASH
pegozafermin
hypertriglyceridemia
Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases
Fierce Biotech
Tue, 07/20/21 - 12:27 pm
Rivus Pharmaceuticals
type 2 diabetes
NASH
hypertriglyceridemia
heart failure with preserved ejection fraction
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia Treatment
Motley Fool
Wed, 01/29/20 - 10:42 am
Akcea Therapeutics
Ionis Pharmaceuticals
hypertriglyceridemia
AKCEA-ANGPTL3-Lrx
clinical trials
Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx
Yahoo/Benzinga
Mon, 03/31/14 - 11:25 am
Isis Pharmaceuticals
ISIS-APOCIIIRx
hypertriglyceridemia
AstraZeneca says FDA accepts application for Epanova
The Fly on the Wall
Wed, 09/18/13 - 08:46 am
AstraZeneca
FDA
Epanova
hypertriglyceridemia
Acasti announces positive phase 2 open label clinical trial result
The Fly on the Wall
Tue, 08/13/13 - 11:04 am
Acasti
clinical trials
CaPre
hypertriglyceridemia
Isis Pharma drug reduces blood fat by 64 pct in mid-stage study
Reuters
Mon, 07/22/13 - 10:45 am
Isis Pharmaceuticals
hypertriglyceridemia
ISIS-APOCIIIRx
Isis Drug Shuts Down Gene Causing Higher Blood-Fat Levels
TheStreet.com
Tue, 06/25/13 - 11:02 am
Isis Pharmaceuticals
Amarin
Sanofi
ISIS-APOCIIIRx
hypertriglyceridemia
The Good News Is This Can Only Go on for 5 Years
Motley Fool
Sat, 12/15/12 - 01:13 pm
Amarin
Vascepa
dyslipidemia
hypertriglyceridemia
Amarin Declines as Investors Wait on Drug’s Exclusivity Decision
Bloomberg
Wed, 10/10/12 - 11:51 am
Amarin
exclusivity
Vascepa
hypertriglyceridemia
Phase I trial of novel HER2/neu Antigens will Start at Mayo; Isis Initiates Phase 2 Study of ISIS-APOCIIIRx
BioMedReports
Sat, 05/5/12 - 04:31 pm
TapImmune
HER-2/neu vaccine
vaccines
Isis Pharmaceuticals
ISIS-APOCIIIRx
hypertriglyceridemia
Amarin ($AMRN) shares soar on promising Ph3 triglyceride study
Fierce Biotech
Mon, 11/29/10 - 10:03 am
Amarin
hypertriglyceridemia
Abbott's TriCor Fails To Beat A Sugar Pill
Forbes
Mon, 03/15/10 - 10:14 am
Abbott Laboratories
TriCor
hypertriglyceridemia
Isis Pharmaceuticals Adds New Cardiovascular Drug to Development Pipeline
Yahoo
Mon, 01/11/10 - 10:55 am
Isis Pharmaceuticals
ISIS-APOCIIIRx
hypertriglyceridemia